Our vision is to save your vision
 
Choose Language
  • French
  • Deutsch
  • Italian
  • Russian
  • Japanese
  • Espanol
  • English
Connect and Share
Color: 
    Color Color Color Color
Type size: 
    Size Size Size Size
    Join

Main menu

Skip to primary content
Skip to secondary content
  • Learn
  • Treat
  • Resources
  • Connect
  • About
  • Donate

Science of AMD Newsfeed

  • FDA approves faricimab for treatment of wet AMD and DME
  • Novartis Provides Update on Use and Safety of Beovu in Patients With Wet AMD
  • Beovu Approved for Wet AMD in European Union
  • AMD Incidence to Rise by 75% and Affect 77 million Europeans by 2050
  • Opthea OPT-302 Combo Outshines Lucentis Alone
  • Positive phase 2 trial results of anti-VEGF abicipar pegol for treating wet AMD
  • Vitreous separation in wet AMD patients linked to fewer anti-VEGF injections
  • As-needed anti-VEGF regimen shown to be effective for the treatment of wet AMD
  • Greatest vision gains occur during early stages of anti-VEGF treatment for wet AMD
  • Potential Topical Treatment in the Future for Macular Degeneration
  • MicroRNAs Block Abnormal Blood Vessel Growth While Still Maintaining the Health of Normal Vessels
  • New Treatment Approach in Mice Regresses Abnormal Vessels in Wet Macular Degeneration
  • Discussions on the Retina and AMD from the American Academy of Opthalmology 2013: Hear from the Experts
  • New Initiative by the American Academy of Ophthalmology Harnesses Technology to Improve Patient Outcomes
  • Download Wet AMD Report
  • Glossary
  • Contact Us
  • Privacy Policy
  • Disclaimer
  • Supporters
The Angiogenesis Foundation - One Broadway, 14th fl, Cambridge, MA 02142, (617) 401-2779 amd@angio.org
This website is certified by Health On the Net Foundation. Click to verify.
This site has been determined by HON in Geneva, Switzerland to comply with standards for trustworthy health information.